Loading clinical trials...
Loading clinical trials...
The goal of this study is to compare two approaches for commencing pharmacotherapy with injectable buprenorphine for opioid use disorder (OUD) among jail inmates: (1) at the time of admission or (2) s...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
NYU Langone Health
Collaborators
NCT04587791 · Chronic Pain, Opioid Use Disorder
NCT07421102 · Opioid Use Disorder
NCT05492825 · Substance Use Disorders, Chronic Pain, and more
NCT05942313 · Opioid Use Disorder, Pregnancy Related
NCT07466784 · Opioid Use Disorder, Opioid Abuse or Dependence, and more
NYU Langone Health
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions